SYNTHETIC GENES
    4.
    发明公开
    SYNTHETIC GENES 审中-公开
    SYNTHETISCHE基因

    公开(公告)号:EP1576140A4

    公开(公告)日:2007-08-08

    申请号:EP03798802

    申请日:2003-09-26

    摘要: The invention provides strategies, methods, vectors, reagents, and systems for production of synthetic genes, production of libraries of such genes, and manipulation and characterization of the genes and corresponding encoded polypeptides. In one aspect, the synthetic genes can encode polyketide synthase polypeptides and facilitate production of therapeutically or commercially important polyketide compounds.

    摘要翻译: 本发明提供了用于生产合成基因的策略,方法,载体,试剂和系统,这些基因文库的生产以及基因和相应编码多肽的操作和表征。 一方面,合成基因可编码聚酮化合物合酶多肽并促进产生治疗或商业上重要的聚酮化合物。

    Synthesis of oligoketides
    6.
    发明公开
    Synthesis of oligoketides 审中-公开
    合成喔寡核苷酸

    公开(公告)号:EP1754700A2

    公开(公告)日:2007-02-21

    申请号:EP06120607.4

    申请日:2000-01-27

    CPC分类号: C07C327/30

    摘要: Facile methods for preparing diketide and triketide thioesters are disclosed. The resulting thioesters may be used as intermediates in the synthesis of desired polyketides, and may contain functional groups which ultimately reside in side chains on the resulting polyketide and thus can be used further to manipulate the polyketide so as to form derivatives. The polyketides produced may also be tailored by glycosylation, hydroxylation and the like. New polyketides and their derivatives and tailored forms are thereby produced.

    摘要翻译: 公开了制备二酮化合物和三酮化物硫酯的简便方法。 所得硫酯可用作合成所需聚酮化合物的中间体,并且可以含有最终存在于所得聚酮化合物上的侧链中的官能团,因此可以进一步用于操作聚酮化合物以形成衍生物。 产生的聚酮化合物也可以通过糖基化,羟基化等来定制。 由此生产新的聚酮化合物及其衍生物和定制的形式。

    POLYKETIDE DERIVATIVES
    10.
    发明公开
    POLYKETIDE DERIVATIVES 审中-公开
    POLYKETID衍

    公开(公告)号:EP1282626A2

    公开(公告)日:2003-02-12

    申请号:EP01935329.1

    申请日:2001-05-10

    IPC分类号: C07D498/18 C12P17/18

    CPC分类号: C07D498/18

    摘要: The present invention relates to novel polyketides, host cells that produce the novel compounds, and methods for their use. The compounds of the present invention are cyclic polyketides (also referred to as a 'macrolides' or 'macrolactones') that include Formula (I) as part of their structure and bind to a FK binding protein wherein R?4 and R5¿ are each selected from the group consisting of hydrogen, methyl, ethyl, and methoxy, provided that at least one of R?4 and R5¿ is hydrogen, methyl, or ethyl. As will be explained in greater detail below, the compounds of the present invention have properties such as favorable P450 enzyme activity profiles that are desirable for use of these compounds as drugs.